The importance of assessing the dose actually administered in pharmacokinetic trials. | Clin Pharmacol Ther;77(4): 235-40, 2005 Apr. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

The importance of assessing the dose actually administered in pharmacokinetic trials.

Buclin, Thierry; Perrottet, Nancy; Biollaz, Jerome.

Affiliation

Buclin T; Division of Clinical Pharmacology and Toxicology, Beaumont 633, University Hospital of Lausanne (CHUV), 1011 Lausanne, Switzerland. thierry.buclin@chuv.hospvd.ch

Clin Pharmacol Ther ; 77(4): 235-40, 2005 Apr.

Article in En | MEDLINE | ID: mdl-15903121

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Drugs, Investigational / Clinical Trials as Topic Type of study: Guideline / Prognostic_studies Limits: Humans Language: En Journal: Clin Pharmacol Ther Year: 2005 Document type: Article Affiliation country:

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Drugs, Investigational / Clinical Trials as Topic Type of study: Guideline / Prognostic_studies Limits: Humans Language: En Journal: Clin Pharmacol Ther Year: 2005 Document type: Article Affiliation country: